Medical Events

Oncocyte Physician/KOL Education Webinar Library

Oncocyte events is a source for medical information related to the Determa line of diagnostics.

Oncocyte events is a source for medical information related to the Determa line of diagnostics.

Bios

Dr. Johannes Kratz is the Director of Minimally Invasive and Robotic Thoracic Surgery and Van Auken Endowed Chair in Thoracic Oncology at the University of California, San Francisco (UCSF). Dr. Kratz played a pivotal role in the development of the DetermaRx test during his time working with David M. Jablons, M.D. and Michael Mann, M.D. as a research fellow in the Thoracic Oncology Lab at UCSF, and is now a Principal Investigator researching the genetic and immunological mechanisms that drive early-stage lung cancer. His work has been published in leading medical journals including the Lancet, JAMA, and the Journal of Thoracic Oncology. Dr. Kratz has been the recipient of numerous awards and honors including the Partners Healthcare Resident/Fellow as Teacher Award, Willard M. Daggett Award, Edward Churchill Surgical Research Fellowship, Wyeth Scholarship of the American College of Surgeons, John E. Thayer Scholarship Award, Howard Hughes Medical Fellows Program Continued Support Award, Howard Hughes Medical Student Research Fellowship, and designation as a Soma Weiss Scholar. He graduated magna cum laude from Harvard Medical School and holds a Masters in Philosophy from Stanford.
https://cdn.filestackcontent.com/s7I39Q4RjqjjZp2ikpVg
Johannes R. Kratz, M.D., FACP
Assistant Professor of Surgery Division of Adult Cardiothoracic Surgery Van Auken Endowed Chair in Thoracic Oncology Director, Minimally Invasive and Robotic Thoracic Surgery Associate Director, Thoracic Surgery Residency Program
View more >>
Dr. David Gandara is a Professor of Medicine Emeritus at the University of California at Davis and the Director of Thoracic Oncology at the UC Davis Comprehensive Cancer Center (UCDCCC). He is an internationally known clinician-scientist and lung cancer thought leader. Dr. Gandara has led many notable research projects in lung cancer, including early therapeutics trials at various phases, cooperative group trial through the Southwest Oncology Group (SWOG), and translational science projects. He is the clinical director for a National Cancer Institute (NCI) award to the California Cancer Consortium for Early Therapeutic Trials of New Anti-Cancer Agents. He is past chair of the Southwest Oncology Group (SWOG) Lung Committee, and a member and founding co-chair of the NCI-directed Investigational Drug Steering Committee (IDSC). Dr. Gandara has written over 700 articles, book chapters, abstracts and editorials. He is editor-in-chief of the journal Clinical Lung Cancer. He served as president of the International Association for the Study of Lung Cancer (IASLC) from 2009-2011 and served as treasurer from 2013-2017. He is a prior board member and secretary-treasurer of the American Society for Clinical Oncology (ASCO).
https://cdn.filestackcontent.com/LzUNiXKRTiEIvl4OJwlA
David R. Gandara, M.D.
Professor of Medicine Emeritus at the University of California at Davis and the Director of Thoracic Oncology at the UC Davis Comprehensive Cancer Center (UCDCCC)
View more >>
will fill approved bio
https://cdn.filestackcontent.com/uiFzb6vRGiM5dDJfoxS2
Gavitt Woodard, MD
Assistant Professor, Thoracic Surgery, Yale University
View more >>

Social Accounts

Video

Press Contacts

Chelli Miller
219-921-6823